Concepedia

Author

Ermenegildo Arnoldi

Istituti Clinici di Perfezionamento

Also Known As

Diana Crivellari, E Arnoldi, E. Arnoldi, Ermenegildo Arnoldi

31

Publications

1.2K

Citations

14

H-Index

20

Concepts

All Affiliations

Istituti Clinici di PerfezionamentoOspedale San CarloOspedale G.B. Morgagni - L.PierantoniOspedale A. PerrinoIstituto Oncologico Romagnolo
EA

About

Ermenegildo Arnoldi is an author at Istituti Clinici di Perfezionamento specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

472

2

Pharmacology

2

2

47

3

Obstetrics

1

1

14

4

Pathology

1

1

411

5

Gynecologic Surgery

1

1

14

Ermenegildo Arnoldi

×

11

Publications

977

Citations

11

H-Index

YearCitations

Successful Validation of the Palliative Prognostic Score in Terminally Ill Cancer Patients

Marco Maltoni, Oriana Nanni, M Pirovano,

Journal of Pain and Symptom Management

1999

411

Impact of delirium on the short term prognosis of advanced cancer patients

Augusto Caraceni, Oriana Nanni, Marco Maltoni,

Cancer

2000

204

Prediction of survival of patients terminally III with cancer. Results of an Italian prospective multicentric study

Marco Maltoni, M Pirovano, Emanuela Scarpi,

Cancer

1995

197

Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation

Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro,

Journal of Clinical Oncology

2023

31

High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study

Roberto Labianca, Stefano Cascinu, L. Frontini,

Annals of Oncology

1997

30

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

Francesca Battaglin, Marta Schirripa, Federica Buggin,

BMC Cancer

2018

22

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Silvana Leo, Ermenegildo Arnoldi, Lazzaro Repetto,

The Oncologist

2018

21

Comprehensive Geriatric Assessment in Elderly Cancer Patients: An Experience in an Outpatient Population

Ermenegildo Arnoldi, Maria Dieli, Marina Mangia,

Tumori Journal

2007

19

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

Alberto Sobrero, Alberto Zaniboni, Giovanni Luca Frassineti,

Annals of Oncology

2000

17

Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report.

Maria Antonella Bardi, Ermenegildo Arnoldi, G Pizzocchero,

PubMed

1994

14

Page 1